Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway.

Zhu, Jufan; Wang, Luo; Yang, Yuanjun; Han, Mengfei; Yang, Yiheng; Feng, Renqian; Hu, Yan

Zhu, Jufan; Wang, Luo; Yang, Yuanjun; Han, Mengfei; Yang, Yiheng; Feng, Renqian; Hu, Yan.

Afiliación

Zhu J; Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Wang L; Medical College of Zhejiang University, Hangzhou, Zhejiang, China.
Yang Y; Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Han M; Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yang Y; Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Feng R; Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Hu Y; Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

J Investig Med ; 71(5): 511-525, 2023 06.

Article en En | MEDLINE | ID: mdl-36859802

Asunto(s)

Neoplasias Pulmonares; Neoplasias Ováricas; Humanos; Femenino; Afatinib/farmacología; Afatinib/uso terapéutico; Receptores ErbB/genética; Recurrencia Local de Neoplasia; Proliferación Celular; Neoplasias Ováricas/tratamiento farmacológico; Daño del ADN; Línea Celular Tumoral; Neoplasias Pulmonares/tratamiento farmacológico

Palabras clave

DNA damage; ErbB receptors; Ovarian neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Idioma: En Revista: J Investig Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google